Morad, S. A., Levin, J., Shanmugavelandy, S. S., Kester, M., Fabrias, G., Bedia, C., & Cabot, M. C. (2012). Ceramide-antiestrogen nanoliposomal combinations – novel impact of hormonal therapy in hormone-insensitive breast cancer.
Chicago Style aipamenaMorad, Samy A.F., Jonathan Levin, Sriram S. Shanmugavelandy, Mark Kester, Gemma Fabrias, Carmen Bedia, and Myles C. Cabot. Ceramide-antiestrogen Nanoliposomal Combinations – Novel Impact of Hormonal Therapy in Hormone-insensitive Breast Cancer. 2012.
MLA aipamenaMorad, Samy A.F., et al. Ceramide-antiestrogen Nanoliposomal Combinations – Novel Impact of Hormonal Therapy in Hormone-insensitive Breast Cancer. 2012.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.